Skip to content

Immunovant

US · IMVT #1790 by market cap Listed 2017
32.04 -0.07 -0.22%
Live - 5344 symbols - heartbeat 9s ago · 2026-10-08 08:25
Pre-market 31.31 -2.28%
After-hours 32.04 0.00%
Overnight 30.98 -3.31%
Market cap
6.62B
P/B
9.00
EPS
-2.77
Reader sentiment Are you bullish or bearish on IMVT?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/8/10
  • LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $53
    Market Newswire · 2026/9/26
  • Rating change
    H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/5/26
  • Rating change
    J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/5/27
  • Rating change
    LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $53
    Market Newswire · 2026/7/9
  • Rating change
    A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $40 to $45
    Market Newswire · 2026/5/22
  • Rating change
    Guggenheim Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $62
    Market Newswire · 2026/5/26
  • Rating change
    Wells Fargo Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/4/28
  • Rating change
    LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/5/23
  • Rating change
    A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $41 to $66
    Market Newswire · 2026/8/8
  • Truist Financial Maintains Immunovant(IMVT.US) With Hold Rating
    Market Newswire · 2026/9/24
  • Rating change
    Stifel Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $57
    Market Newswire · 2026/8/13
  • Bernstein Initiates Immunovant(IMVT.US) With Hold Rating, Announces Target Price $37
    Market Newswire · 2026/9/26
  • H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $41
    Market Newswire · 2026/9/24
  • Rating change
    H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $41
    Market Newswire · 2026/8/7
  • Rating change
    J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/8/4
  • Piper Sandler Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $66
    Market Newswire · 2026/9/21
  • Rating change
    Citi Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $61
    Market Newswire · 2026/6/30
  • Rating change
    Stifel Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $49
    Market Newswire · 2026/5/25
  • Rating change
    J.P. Morgan Sticks to Their Buy Rating for Immunovant (IMVT)
    TipRanks · 2026/8/10

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:25:11 · For reference only, not investment advice and not tailored to your situation.